371 related articles for article (PubMed ID: 3057923)
1. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
[TBL] [Abstract][Full Text] [Related]
2. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
[TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
[TBL] [Abstract][Full Text] [Related]
4. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
6. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
[TBL] [Abstract][Full Text] [Related]
7. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
Rasmussen SA
Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
[TBL] [Abstract][Full Text] [Related]
8. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
Zohar J; Kaplan Z; Benjamin J
J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
[TBL] [Abstract][Full Text] [Related]
9. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
[TBL] [Abstract][Full Text] [Related]
10. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
Mavissakalian M; Turner SM; Michelson L; Jacob R
Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
[TBL] [Abstract][Full Text] [Related]
11. Double-blind controlled study in phobias and obsessions.
Karabanow O
J Int Med Res; 1977; 5 Suppl 5():42-8. PubMed ID: 340306
[TBL] [Abstract][Full Text] [Related]
12. A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.
Leonard HL; Swedo SE; Lenane MC; Rettew DC; Cheslow DL; Hamburger SD; Rapoport JL
Arch Gen Psychiatry; 1991 Oct; 48(10):922-7. PubMed ID: 1929762
[TBL] [Abstract][Full Text] [Related]
13. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
[TBL] [Abstract][Full Text] [Related]
15. Rebound withdrawal reactions due to clomipramine.
Diamond BI; Borison RL; Katz R; DeVeaugh-Geiss J
Psychopharmacol Bull; 1989; 25(2):209-12. PubMed ID: 2690164
[No Abstract] [Full Text] [Related]
16. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
DeVeaugh-Geiss J; Landau P; Katz R
Psychopharmacol Bull; 1989; 25(1):36-40. PubMed ID: 2672070
[TBL] [Abstract][Full Text] [Related]
17. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
Thorén P; Asberg M; Cronholm B; Jörnestedt L; Träskman L
Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690
[TBL] [Abstract][Full Text] [Related]
18. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
Pato MT; Hill JL; Murphy DL
Psychopharmacol Bull; 1990; 26(2):211-4. PubMed ID: 2236458
[TBL] [Abstract][Full Text] [Related]
19. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder.
Pigott TA; Pato MT; L'Heureux F; Hill JL; Grover GN; Bernstein SE; Murphy DL
J Clin Psychopharmacol; 1991 Aug; 11(4):242-8. PubMed ID: 1918422
[TBL] [Abstract][Full Text] [Related]
20. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
